RBM Survey Report Manchester VAMC - Womens Clinic-Final.pdf

PDF 9 MB Posted Aug 1, 2023

Attached to: Y1DA--608-317 Women's Health Clinic - Manchester VAMC - DBB
Solicitation number: 36C77623R0050
Issued by: Department of Veterans Affairs Technology Acquisition Center Austin

About this file

Written by GovTribe AI · Dec 28, 2023

This document is a regulated building materials survey report for the A/E design services to upgrade the Women's Health Clinic at the Manchester VA Medical Center in Manchester, New Hampshire. The survey identified four asbestos containing materials totaling approximately 7,250 square feet that will require abatement as part of the clinic upgrade project. Limited lead paint sampling found none of the tested surfaces exceeded HUD standards. Polychlorinated biphenyl sampling of two building materials found them to be non-regulated. The report provides location and quantity details of the asbestos, lead, and PCB findings to inform development of an abatement scope and clinic upgrade design for Solicitation 36C77623R0050 issued by the Department of Veterans Affairs Technology Acquisition Center Austin.

View the file

Other files

File	Type	Posted
085113 Aluminum Windows for amendment 0008.pdf	PDF	Aug 8, 2023
36C77623R0050 0008.docx	DOCX document	Aug 8, 2023
36C77623R0050 0007.docx	DOCX document	Aug 3, 2023
36C77623R0050 0006.docx	DOCX document	Aug 1, 2023
6670-AQ201 EQUIPMENT SCHEDULE-6670-AQ201 EQUIPMENT SCHEDULE.pdf	PDF	Jul 25, 2023
6670-AS801 DOOR _ WINDOW SCHEDULES mca-DOOR _ WINDOW SCHEDULES.pdf	PDF	Jul 25, 2023
Specs 01-13 Combined.pdf	PDF	Jul 25, 2023
36C77623R0050 0005.docx	DOCX document	Jul 25, 2023
6670-AS301 EXTERIOR ELEVATIONS-EXTERIOR ELEVATIONS.pdf	PDF	Jul 25, 2023
36C77623R0050 0004_1.docx	DOCX document	Jul 13, 2023
0004 Attachment 13 - Manchester RFIs 1 of 2 -SMRT.pdf	PDF	Jul 13, 2023
0004 Attachment 14 - Manchester RFIS - 2 of 2 - SMRt reponses.pdf	PDF	Jul 13, 2023
36C77623R0050 0004.pdf	PDF	Jul 7, 2023
36C77623R0050 0003.docx	DOCX document	Jul 6, 2023
36C77623R0050 0002.docx	DOCX document	Jul 6, 2023
36C77623R0050 0001.docx	DOCX document	Jun 27, 2023
0001 Attachment 1- Site Visit Sign-in Sheet - Manchester.pdf	PDF	Jun 27, 2023
0001 Attachment 2 - 608-317 VA WHC-updated pharmacy area-W110 redesign - phase 3 - r3 6-22-23.pdf	PDF	Jun 27, 2023
S02 ATT 5 608-317 WHC DRAWINGS-Part3.pdf	PDF	Jun 14, 2023
36C77623R0050_1.docx	DOCX document	Jun 14, 2023
S02 ATT 3 608-317 WHC DRAWINGS-Part1.pdf	PDF	Jun 14, 2023
S02 ATT 7 JA - WHC-Redacted.pdf	PDF	Jun 14, 2023
S02 ATT 10 Contractor Safety-Enviro Form.pdf	PDF	Jun 14, 2023
S02 ATT 8 Wage Rates Hillsborough Cnty.pdf	PDF	Jun 14, 2023
S02 ATT 6 SITE VISIT INSTRUCTIONS.pdf	PDF	Jun 14, 2023
S02 ATT 4 608-317 WHC DRAWINGS-Part2.pdf	PDF	Jun 14, 2023
S02-ATT 1 Combined ARCH Specs.pdf	PDF	Jun 14, 2023
S02 ATT 9 - PPQ.pdf	PDF	Jun 14, 2023
S02 ATT 11 Limitations on SubContracting.pdf	PDF	Jun 14, 2023
S02-ATT 2 Combined MEP Specs.pdf	PDF	Jun 14, 2023

Show all 30

On GovTribe

Work with this file

Download the original file
Contacts named in this file
Similar government files
Ask GovTribe AI about this file

Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

REGULATED BUILDING MATERIALS

SURVEY REPORT

MANCHESTER VAMC

WOMEN’S HEALTH CLINIC

A/E Design Services for Women’s Health Clinic VA Project No. 608-317 781 Smyth Road Manchester, NH 03104

September 23, 2021

Mabbett Project No.: R2020005.000

Prepared for:

Michael Avramides Architects 319 E. 50th St., Studio E New York, NY 10022

Mabbett & Associates, Inc.

105 Central Street, Suite 4100 Stoneham, MA 02180-1260 T. 781-275-6050 Massachusetts | Virginia | Rhode Island | New York

www.mabbett.com

REGULATED BUILDING MATERIALS SURVEY REPORT

A/E Design Services to Upgrade Women’s Health Clinic | Manchester VAMC

ACKNOWLEDGEMENT

This Regulated Building Materials Survey Report has been prepared by Mabbett & Associates, Inc. (Mabbett®) for the A/E Design Services to Upgrade Women’s Health Clinic at the Manchester Veterans Affairs (VA) Medical Center located at 781 Smyth Road in Manchester, New Hampshire, VA Project No. 608-317. The information presented herein is based on the facts and information conveyed to or received by Mabbett during the preparation of this report. If any of the information provided to Mabbett that was used in preparing this report is incorrect, incomplete, or subject to change, Mabbett would wish to alter its opinion(s) accordingly. In addition, the professional opinions and information contained in this report are based solely on the requirements of the applicable regulations and technical data as known to Mabbett as of the date of this report and considered applicable to this report.

The attached Regulated Building Materials Survey Report was prepared by Mr. Kevin M. Donovan, Senior Environmental, Health & Safety Specialist of Mabbett & Associates, Inc.

This report has been reviewed and approved by:

Michael F. Delaney Director, Building Sciences Group

TABLE OF CONTENTS

SECTION PAGE

1.0 INTRODUCTION

1.1 Summary of Survey Results

1.2 Purpose and Objectives

2.0 ASBESTOS SURVEY

2.1 Sampling Methodology

2.2 Analytical Methodology

2.3 Summary of Asbestos Containing Materials Findings

3.0 LEAD CONTAINING PAINT SAMPLING

4.0 BUILDING MATERIAL PCB SAMPLING

5.0 CONCLUSIONS AND RECOMMENDATIONS

5.1 Asbestos

5.2 Lead Containing Paint

5.3 PCB Containing Material

6.0 LIMITATIONS

TABLES

Table 1 – Summary of Identified ACM (in text) Table 2 – Summary of Lead Paint Chip Analytical Results (in text) Table 3 – Summary of PCB Analytical Results (in text)

FIGURES

1 – Asbestos, Pb and PCB Sampling Location Plan – WHC, Basement 2 – Asbestos, Pb and PCB Sampling Location Plan – WHC, First Floor

APPENDICES

Appendix A – Summary of ACM Building Survey Results, Including Negative Results Appendix B – Asbestos Laboratory Reports and Chain of Custody Appendix C – Lead Paint Chip Laboratory Reports and Chain of Custody Appendix D – PCB Laboratory Reports and Chain of Custody

1.0 INTRODUCTION

Mabbett and Associates, Inc. (Mabbett®) performed a survey for regulated building materials (RBM) as part of the A/E Design Services to Upgrade Women’s Health Clinic at the Manchester VA Medical Center (VAMC) located at 781 Smyth Road in Manchester, New Hampshire. The site survey was performed by Mr. Kevin M. Donovan of Mabbett on August 27, 2020 and September 17, 2021 and consisted of the following activities:

A review of the previous regulated building material reports and recent abatement projects;

An Asbestos Containing Material (ACM) survey of suspect materials (Analysis by Polarized Light Microscopy

[PLM]);

Lead Containing Paint (LCP) sampling (Analysis by atomic absorption [AA]); and Polychlorinated Biphenyls (PCB) Containing Building Materials sampling (analysis performed by SW-846 Method

8082A).

The survey was limited to areas that may be impacted by the planned Women’s Health Clinic project. Sampling locations were determined based upon inspection of each location. Areas and materials outside of this scope of work were not surveyed by Mabbett.

1.1 Summary of Survey Results

Bulk samples of suspected ACM were collected and submitted to a certified analytical laboratory for asbestos analysis by PLM using stop positive methodology. Paint chip and building material PCB samples were collected and submitted to a certified analytical laboratory for analysis. The survey efforts yielded the following results and conclusions:

Seventy (70) bulk samples for suspect ACM were collected in the building.

Based on laboratory analysis of suspect ACM and review of previous asbestos survey data, four (4) of the identified materials contained asbestos greater than 1%. The Environmental Protection Agency (EPA) and the Occupational Safety and Health Administration (OSHA) defines ACM as any material that contains greater than one percent (>1%) asbestos.

Ten (10) paint chip samples from building surfaces were collected for laboratory analysis and reporting.

Based on laboratory analysis of paint chips, none of the collected samples revealed concentrations of lead in paint that exceeded the U.S. Department of Housing and Urban Development (HUD) threshold of 0.5 percent by weight.

Two (2) bulk samples of suspect PCB containing building materials were collected for laboratory analysis and reporting.

Based on laboratory analysis of suspect PCB materials, the materials sampled were non TSCA regulated material are not considered a TSCA regulated PCB Bulk Product Waste.

1.2 Purpose and Objectives

The regulated building material survey was comprised of three primary project tasks including:

Evaluation of existing site conditions and formulation of a sampling plan.

Site survey to collect building material samples for laboratory analysis.

Development of this Regulated Building Materials Survey Report.

This project was designed to accomplish two primary objectives: to collect a representative number of building materials for laboratory analysis and reporting; and to use data from the laboratory analysis efforts to estimate the volume of regulated building materials present within the building’s interior and exterior for subsequent use in

© 2021, Mabbett & Associates, Inc. 2 September 23, 2021 Mabbett Project No. R2020005.000 S:\ADMINA\2020005 M Avramides Manchester VAMC\000\RBM Survey Report Manchester VAMC - Womens Clinic-Final.doc development of an abatement scope and design. These objectives were met through a combination of a site visit and inspection to collect building material samples for laboratory analysis; and interpretation of qualitative data collected in the field; and the quantitative laboratory data generated from analysis of the building materials as summarized in this survey report.

2.0 ASBESTOS SURVEY

A visual screening inspection was conducted by a trained and accredited inspector to identify locations of suspect ACM and conceptualize the sampling program. Only areas that were accessible during the field work phase were inspected, with reasonable efforts made during the initial field survey work to access areas as necessary to complete the asbestos survey and sampling program.

2.1 Sampling Methodology

Bulk asbestos samples were collected using EPA National Emissions Standards for Hazardous Air Pollutants (NESHAP), 40 CFR Part 763, and Asbestos Hazard Emergency Response Act (AHERA) protocols. Bulk suspect ACM sampling was generally conducted according to the following sampling protocol:

Friable surfacing material:

• At least three bulk samples shall be collected from each homogeneous area that is 1,000 ft2 or less.

• At least five bulk samples shall be collected from each homogeneous area that is greater than

1,000 ft2 but less than or equal to 5,000 ft2.

• At least seven bulk samples shall be collected from each homogeneous area that is greater than

5,000 ft2.

Thermal system insulation:

• At least three bulk samples shall be collected from each homogeneous area of thermal system insulation.

• At least one bulk sample shall be collected from each homogeneous area of patched area of thermal system insulation.

• Sufficient samples shall be collected from elbows and fittings to determine if they contain ACM.

• Bulk samples shall not be collected from any homogeneous area where the state licensed asbestos inspector determined that the thermal system insulation is fiberglass, foam glass, rubber, or other non-ACM.

Miscellaneous material:

• At least two bulk sample shall be collected from each homogeneous area that is less than 100 ft2.

• At least three bulk samples shall be collected from each homogeneous area that is greater than

100 ft2.

Examples of areas that were inaccessible, or where the survey was limited to visual observation only, are provided below:

Within walls;

Within fire doors;

Enclosed pipe/duct chases;

Inside mechanical equipment/ductwork;

Above fixed drywall or plaster ceilings; and Electrical equipment.

2.2 Analytical Methodology

The collected bulk samples were submitted under standard chain of custody (COC) procedures to ProScience Analytical Services, Inc. (ProScience) of Woburn, Massachusetts. Sample analysis was conducted by PLM, in accordance with EPA Method 600/R-93/116, using stop positive methodology. ProScience is accredited by the

American Industrial Hygiene Association (AIHA) and participates in the National Voluntary Laboratory Accreditation Program (NVLAP).

Bulk sample results from this inspection are summarized in Appendix A, Summary of ACM Building Inspection Results. The EPA, Occupational Safety and Health Administration (OSHA), and the Massachusetts department of Environmental Protection, defines ACM as any material that contains greater than one percent (>1%) asbestos. As such, the analytical laboratory would identify bulk samples of suspected ACM as positive for asbestos when they met or exceeded the regulatory criteria of greater than one percent (>1%) asbestos. Asbestos analytical laboratory report and the chain of custody is provided in Appendix B of this report.

2.3 Summary of Asbestos Containing Materials Findings

Mabbett identified twenty-four (24) types of homogenous materials and collected seventy (70) representative bulk ACM samples. Asbestos sampling locations and results are identified on Figures 1 and 2. The current and historical laboratory analytical data indicated that four (4) homogeneous materials have greater than 1% asbestos and are ACM. Materials identified as ACM are presented in Table 1 below:

TABLE 1

Summary of ACM

A/E Design Services for Women’s Health Clinic Manchester VA Medical Center

Location Description of Material Percent and Type of Asbestos

Estimated Quantity Amount Units

Basement, Café Area (Rooms B006 and B007)

Black Damp Proofing (On Perimeter Walls) 10% Chrysotile 900 SF

Basement, Café Area (Rooms B006 and B007)

Cement Board Heater Panel (Under Windows) 20% Chrysotile 5 EA

Basement, Café Area (Rooms B006 and B007)

Black Mastic (Under 12” x 12” Floor Tile) 5% Chrysotile 1,350 SF

1st Floor, Old Pharmacy and Offices (Rooms #W104, W106, W107, W108, W110, W111 and W111A)

Black Damp Proofing (On Perimeter Walls) 10% Chrysotile 2,000 SF

1st Floor, Old Pharmacy and Offices (Rooms #W104, W106, W107, W108, W110, W111 and W111A)

Cement Board Heater Panel (Under Windows) 20% Chrysotile 9 EA

1st Floor, Old Pharmacy (Rooms #W108, W110, W111, and W111A)

Black Mastic (Under 12” x 12” Floor Tile) 5% Chrysotile 4,000 SF

1st Floor, Offices (Rooms #W102, W104, W105 and W106)

Brown Floor Tile (Under Carpet) 7% Chrysotile 800 SF

Notes:

SF = Square Feet EA = Each

3.0 LEAD CONTAINING PAINT SAMPLING

Limited sampling of painted surfaces was conducted on August 27, 2020. The limited LCP survey included the collection of ten (10) paint chips from materials and surfaces that may be impacted by the proposed work. Paint chip samples were submitted under standard COC procedures to ProScience of Woburn, Massachusetts. Analysis was conducted using AA EPA method SW846-7000B/3051. The laboratory analytical report is included in Appendix C of this report.

The results of the limited LCP sampling are summarized in Table 2 below:

TABLE 2

Summary of Lead Paint Chip Analytical Results A/E Design Services for Women’s Health Clinic

Manchester VA Medical Center

Sample # Sample Location Substrate and Component Color Result (mg/Kg)

Pb-01 Room #W107 Metal Radiator Cover Tan <RL Pb-02 Room #W107 Metal Door Frame Tan 0.042

Pb-03 Room #W110 Metal Door Green <RL

Pb-04 Room #W110 Gypsum Wall Green <RL Pb-05 Room #W106 Metal Windowsill Tan 0.09

Pb-06 Room #W105 Plaster Wall Green 0.24

Pb-07 Basement, Cafe Gypsum Wall Tan <RL Pb-08 Basement, Cafe Metal Radiator Cover Tan 0.047 Pb-09 Exterior - Front Metal Railing Brown 0.020 Pb-10 Exterior - Front Metal Door Brown <RL

Notes:

<RL = Less Than the Reporting Limit

4.0 BUILDING MATERIAL PCB SAMPLING

As part of this regulated building materials survey, Mabbett conducted sampling of suspect building materials for PCB.

Mabbett sampled two (2) homogenous areas of suspect PCB-containing materials. PCB bulk samples were submitted under standard COC procedures to Alpha Analytical of Westborough, Massachusetts. Analysis was conducted using EPA Method SW-846 8082A. A copy of the lab report detailing the findings of this sampling is provided in Appendix D. Results of this PCB sampling are summarized below in Table 3:

TABLE 3

Summary of PCB Analytical Results

A/E Design Services for Upgrade Women’s Health Clinic Manchester VA Medical Center

Sample # Sample Location Description of Material Result (ppm)

PCB 01 Exterior Front Window Caulk 0.754 PCB 02 Exterior Front Door Caulk 2.26

Notes:

PPM = Parts Per Million

5.0 CONCLUSIONS AND RECOMMENDATIONS

5.1 Asbestos

Identified ACM materials must be removed by a licensed asbestos abatement contractor prior to being disturbed by renovation activities. Any suspect materials encountered during renovation or demolition activities that were not identified in this report as being non-ACM should be assumed to be ACM unless sample results prove otherwise.

Suspect ACM that may be present within the walls, above inaccessible hard ceilings, or in other inaccessible locations, should be assumed to contain asbestos if discovered during any renovation or demolition process or until otherwise verified.

5.2 Lead Containing Paint

The purpose of the limited LCP survey was to identify similar areas of LCP. During the on-site survey, representative samples of similar areas of interior and exterior building coatings were collected and analyzed for lead content. The regulations addressing LCP in non-residential buildings are focused on occupational exposures involved with paint-disturbing activities and related waste-disposal activities.

Occupational exposure to lead in construction is regulated by OSHA regulation 29 CFR 1926.62 “Lead in Construction”, as well as other applicable state and local regulations. These regulations involve the air monitoring of workers to determine exposure levels when disturbing paint containing measurable concentrations of lead. A LCP survey cannot determine the safe level of lead for the purpose of paint-disturbing activities but is intended to provide guidance as to the locations of LCP. Employers and contractors may use this information to better determine where worker exposures to airborne lead may occur and, through the interpretation of LCP concentration data, assess the potential magnitude of exposure to their employees and identify the controls necessary to limit health risks.

A concentration of lead greater than or equal to 0.5 mg/Kg percent by weight or 1.0 mg/cm2 exceeds EPA and HUD residential standards is considered an indicator of risk. Representative samples of LCP waste to be generated during building renovation, or following demolition but prior to disposal, should be collected and analyzed using toxicity characteristic leaching procedure (TCLP) in accordance with 40 CFR Part 261. Management and disposal of lead containing waste must be done in accordance with all applicable local, state, and federal regulations.

OSHA regulations may require certain procedures for any paint that contains lead, even if it is below these levels. All LCP identified, regardless of the lead content, should either be sampled and analyzed by TCLP and then handled/disposed of accordingly, or segregated from other large-scale debris and then managed as hazardous waste in accordance with federal, state, and local hazardous waste disposal regulations.

5.3 PCB Containing Material

The suspect PCB caulk material sampling results determined the materials to be non TSCA regulated material and meets TSCA Excluded PCB Product definition. Excluded PCB Product waste can be managed as solid waste at any landfill permitted to accept waste with PCB levels up to those observed.

6.0 LIMITATIONS

This survey report is the result of a diligent and thorough inspection for regulated building materials of the areas and materials that may be impacted by the proposed work of the Women’s Health Clinic. Inaccessible areas were not included in this survey. Although a comprehensive inspection was performed, Mabbett does not claim to have identified all hazardous materials that could be present in the facility (for example, materials potentially located within the inaccessible areas). Mabbett has conducted this assessment with reasonable care and has performed this project in accordance with generally accepted industry standards. There can be no assurances, and Mabbett makes no assurances, that the information, research, and technology used to prepare this report may not change in the future, thus affecting the results reported herein.

FIGURES

Sampling Location Plans

Scientists I Engineers I Program Managers

Mabbett & Associates, Inc.

105 Central St. Stoneham, MA 02180

T. 781-275-6050 www.mabbett.com

Mabbett

STOP POSITIVE SAMPLE FOR ASBESTOS

NO ASBESTOS DETECTED (NAD)

SAMPLE GREATER THAN 1% ASBESTOS

APPROXIMATE SAMPLE LOCATION

1,2

LEGEND

25**

25*

NOTES;

LEAD SAMPLE LOCATIONPb-01

PCB SAMPLE LOCATIONPCB-01

AutoCAD SHX Text 19C

AutoCAD SHX Text 20B

AutoCAD SHX Text Pb-07

AutoCAD SHX Text Pb-08

AutoCAD SHX Text 19B

AutoCAD SHX Text 19A

AutoCAD SHX Text 20A

AutoCAD SHX Text

PCB-01

AutoCAD SHX Text Drawing Title

AutoCAD SHX Text Approved: Project Director

AutoCAD SHX Text Project Title

AutoCAD SHX Text Date

AutoCAD SHX Text Location

AutoCAD SHX Text Checked

AutoCAD SHX Text Building Number

AutoCAD SHX Text Project Number

AutoCAD SHX Text Drawing Number

AutoCAD SHX Text Drawn

AutoCAD SHX Text Dwg. of

AutoCAD SHX Text Date

AutoCAD SHX Text

ARCHITECT/ENGINEERS:

AutoCAD SHX Text Office of Construction and Facilities Management

AutoCAD SHX Text Revisions:

AutoCAD SHX Text one eighth inch = one foot

AutoCAD SHX Text

AutoCAD SHX Text B

AutoCAD SHX Text A

AutoCAD SHX Text C

AutoCAD SHX Text D

AutoCAD SHX Text E

AutoCAD SHX Text F

AutoCAD SHX Text three inches = one foot

AutoCAD SHX Text 6"

AutoCAD SHX Text

AutoCAD SHX Text 6"

AutoCAD SHX Text one and one half inches = one foot

AutoCAD SHX Text one inch = one foot

AutoCAD SHX Text

AutoCAD SHX Text 6"

AutoCAD SHX Text

AutoCAD SHX Text three quarters inch = one foot

AutoCAD SHX Text one half inch = one foot

AutoCAD SHX Text

AutoCAD SHX Text three eighths inch = one foot

AutoCAD SHX Text

AutoCAD SHX Text one quarter inch = one foot

AutoCAD SHX Text

VA FORM 08-6231

AutoCAD SHX Text

AutoCAD SHX Text F

AutoCAD SHX Text E

AutoCAD SHX Text D

AutoCAD SHX Text C

AutoCAD SHX Text B

AutoCAD SHX Text A

AutoCAD SHX Text

SEAL

AutoCAD SHX Text Description:

AutoCAD SHX Text

ARCHITECT/ENGINEERS:

AutoCAD SHX Text 608-317

AutoCAD SHX Text

718 SMYTH RD, MANCHESTER, NH

AutoCAD SHX Text

WOMEN'S HEALTH CLINIC

AutoCAD SHX Text

ASBESTOS, LEAD AND PCB SURVEY

AutoCAD SHX Text

BASEMENT

AutoCAD SHX Text

DEMOLITION

AutoCAD SHX Text

1-AD101

AutoCAD SHX Text

PEH

AutoCAD SHX Text

MFD

AutoCAD SHX Text 9/17/2020

AutoCAD SHX Text

VAPAHCS PLANNING AND ENGINEERING

AutoCAD SHX Text

23A*, 23B*

24A, 24B

APPENDIX A

Summary of ACM Building Survey Results, Including Negative Results

Appendix A Summary of ACM Sampling Results

A/E Design Services for Women's Health Clinic Manchester VA Medical Center

Sample

No. Sample Location Description of Material Percent and Type of Asbestos

01A Room #W110 2' x 2' White Ceiling Tile (Fissured) NAD

01B Room #W108 2' x 2' White Ceiling Tile (Fissured) NAD

01C Room #W107 2' x 2' White Ceiling Tile (Fissured) NAD

02A Room #W111 2' x 2' White Ceiling Tile (Smooth) NAD

02B Room #W111 2' x 2' White Ceiling Tile (Smooth) NAD

02C Room #W111A 2' x 2' White Ceiling Tile (Smooth) NAD

03A Room #W105 2' x 4' White Ceiling Tile (Fissured) NAD

03B Handicap Hallway 2' x 4' White Ceiling Tile (Fissured) NAD

03C Room #W102 2' x 4' White Ceiling Tile (Fissured) NAD

04A Room #W106 Carpet Adhesive NAD

04B Room #W105 Carpet Adhesive NAD

04C Room #W103 Carpet Adhesive NAD

05A Room #W110 Black Damp Proofing 10% Chrysotile

05B Room #W108 Black Damp Proofing NA/PS

05C Room #W103 Black Damp Proofing NA/PS

06A Room #W120 Gray Duct Sealant NAD

06B Room #W111A Gray Duct Sealant NAD

06C Room #W108 Gray Duct Sealant NAD

07A Room #W120 Gypsum Wallboard NAD

07B Room #W107 Gypsum Wallboard NAD

07C Handicap Hallway Gypsum Wallboard NAD

08A Room #W120 Joint Compound NAD

08B Room #W107 Joint Compound NAD

08C Handicap Hallway Joint Compound NAD

09A Room #W110 Wall Plaster (Base Coat) NAD

09B Room #W111 Wall Plaster (Base Coat) NAD

09C Room #W108 Wall Plaster (Base Coat) NAD

09D Room #W107 Wall Plaster (Base Coat) NAD

09E Room #W103 Wall Plaster (Base Coat) NAD

10A Room #W110 Wall Plaster (Finish Coat) NAD

10B Room #W111 Wall Plaster (Finish Coat) NAD

10C Room #W108 Wall Plaster (Finish Coat) NAD

10D Room #W107 Wall Plaster (Finish Coat) NAD

10E Room #W103 Wall Plaster (Finish Coat) NAD

12A Room #W108 Gray Cement Board Heater 20% Chrysotile

12B Room #W108 Gray Cement Board Heater NA/PS

13A Room #W120 Cove Base NAD

Appendix A Summary of ACM Sampling Results

A/E Design Services for Women's Health Clinic Manchester VA Medical Center

Sample

No. Sample Location Description of Material Percent and Type of Asbestos

13B Room #W110 Cove Base NAD

13C Room #W106 Cove Base NAD

14A Room #W120 Cove Base Adhesive NAD

14B Room #W110 Cove Base Adhesive NAD

14C Room #W106 Cove Base Adhesive NAD

15A Room #W107 Gray Sheet Flooring NAD

15B Room #W107 Gray Sheet Flooring NAD

15C Room #W107 Gray Sheet Flooring NAD

16A Room #W107 Gray Sheet Flooring Adhesive NAD

16B Room #W107 Gray Sheet Flooring Adhesive NAD

16C Room #W107 Gray Sheet Flooring Adhesive NAD

17A Room #W120 12" x 12" Floor Tile NAD

17B Room #W110 12" x 12" Floor Tile NAD

17C Room #W108 12" x 12" Floor Tile NAD

18A Room #W120 12" x 12" Floor Tile Mastic 5% Chrysotile

18B Room #W110 12" x 12" Floor Tile Mastic NA/PS

18C Room #W108 12" x 12" Floor Tile Mastic NA/PS

19A Basement - Café Interior Brown Window Frame Caulk NAD

19B Basement - Café Interior Brown Window Frame Caulk NAD

19C Basement - Café Interior Brown Window Frame Caulk NAD

20A Exterior Window Frame Caulk NAD

20B Exterior Window Frame Caulk NAD

20C Exterior Window Frame Caulk NAD

21A Exterior Door Frame Caulk NAD

21B Exterior Door Frame Caulk NAD

21C Exterior Door Frame Caulk NAD

22A Exterior Corner of Building Pink Expansion Joint Caulk NAD

22B Exterior Corner of Building Pink Expansion Joint Caulk NAD

22C Exterior Corner of Building Pink Expansion Joint Caulk NAD

23A Room #W105 Brown Floor Tile (Under Carpet) 7% Chrysotile

23B Room #W105 Brown Floor Tile (Under Carpet) 7% Chrysotile

24A Room #W105 Brown Floor Tile Mastic NAD

24B Room #W105 Brown Floor Tile Mastic NAD

Notes:

NAD = No Asbestos detected NA/PS = Not Analyzed Positive Stop

APPENDIX B

Asbestos Laboratory Reports and Chain of Custody

APPENDIX C

Lead Paint Chip Laboratory Reports and Chain of Custody

APPENDIX D

PCB Laboratory Reports and Chain of Custody

L2035539

Mabbett & Associates

R2020005.000

MANCHESTER VPME

Client:

Project Name:

Project Number:

09/04/20

Eight Walkup Drive, Westborough, MA 01581-1019

Lab Number:

Report Date:

508-898-9220 (Fax) 508-898-9193 800-624-9220 - www.alphalab.com

105 Central street

Suite 4100

Michael DelaneyATTN:

ANALYTICAL REPORT

Certifications & Approvals: MA (M-MA086), NH NELAP (2064), CT (PH-0574), IL (200077), ME (MA00086), MD (348), NJ (MA935), NY (11148), NC (25700/666), PA (68-03671), RI (LAO00065), TX (T104704476), VT (VT-0935), VA (460195), USDA (Permit #P330-17-00196).

Stoneham, MA 02180

(781) 275-6050Phone:

The original project report/data package is held by Alpha Analytical. This report/data package is paginated and should be reproduced only in its entirety. Alpha Analytical holds no responsibility for results and/or data that are not consistent with the original.

Serial_No:09042014:31

L2035539-01

L2035539-02

Alpha Sample ID

PCB-01-WINDOW CAULK

PCB-02-DOOR CAULK

Client ID

MANCHESTER, NH

Sample Location

MANCHESTER VPME

R2020005.000

Project Name:

Project Number:

Lab Number:

Report Date:

L2035539 09/04/20

08/27/20 12:00

Collection Date/TimeMatrix Receive Date

SOLID

08/28/20

MANCHESTER VPME

R2020005.000

Project Name:

Project Number:

Lab Number:

Report Date:

L2035539

09/04/20

Case Narrative

I, the undersigned, attest under the pains and penalties of perjury that, to the best of my knowledge and belief and based upon my personal inquiry of those responsible for providing the information contained in this analytical report, such information is accurate and complete. This certificate of analysis is not complete unless this page accompanies any and all pages of this report.

Authorized Signature:

Title: Technical Director/Representative Date: 09/04/20

The samples were received in accordance with the Chain of Custody and no significant deviations were encountered during the preparation or analysis unless otherwise noted. Sample Receipt, Container Information, and the Chain of Custody are located at the back of the report.

Results contained within this report relate only to the samples submitted under this Alpha Lab Number and meet NELAP requirements for all

NELAP accredited parameters unless otherwise noted in the following narrative. The data presented in this report is organized by parameter

(i.e. VOC, SVOC, etc.). Sample specific Quality Control data (i.e. Surrogate Spike Recovery) is reported at the end of the target analyte list for each individual sample, followed by the Laboratory Batch Quality Control at the end of each parameter. Tentatively Identified

Compounds (TICs), if requested, are reported for compounds identified to be present and are not part of the method/program Target

Compound List, even if only a subset of the TCL are being reported. If a sample was re-analyzed or re-extracted due to a required quality control corrective action and if both sets of data are reported, the Laboratory ID of the re-analysis or re-extraction is designated with an "R" or "RE", respectively.

When multiple Batch Quality Control elements are reported (e.g. more than one LCS), the associated samples for each element are noted in the grey shaded header line of each data table. Any Laboratory Batch, Sample Specific % recovery or RPD value that is outside the listed

Acceptance Criteria is bolded in the report. In reference to questions H (CAM) or 4 (RCP) when "NO" is checked, the performance criteria for CAM and RCP methods allow for some quality control failures to occur and still be within method compliance. In these instances, the specific failure is not narrated but noted in the associated QC Outlier Summary Report, located directly after the Case Narrative. QC information is also incorporated in the Data Usability Assessment table (Format 11) of our Data Merger tool, where it can be reviewed in conjunction with the sample result, associated regulatory criteria and any associated data usability implications.

Soil/sediments, solids and tissues are reported on a dry weight basis unless otherwise noted. Definitions of all data qualifiers and acronyms used in this report are provided in the Glossary located at the back of the report.

HOLD POLICY - For samples submitted on hold, Alpha's policy is to hold samples (with the exception of Air canisters) free of charge for 21 calendar days from the date the project is completed. After 21 calendar days, we will dispose of all samples submitted including those put on hold unless you have contacted your Alpha Project Manager and made arrangements for Alpha to continue to hold the samples. Air canisters will be disposed after 3 business days from the date the project is completed.

Please contact Project Management at 800-624-9220 with any questions.

ORGANICS

PCBS

Aroclor 1016

Aroclor 1221

Aroclor 1232

Aroclor 1242

Aroclor 1248

Aroclor 1254

Aroclor 1260

Aroclor 1262

Aroclor 1268

PCBs, Total

Parameter Result Dilution Factor

ug/kg ug/kg ug/kg ug/kg ug/kg ug/kg ug/kg ug/kg ug/kg ug/kg

Qualifier Units RL

Polychlorinated Biphenyls by GC - Westborough Lab

SAMPLE RESULTS

Project Name:

Project Number:

Lab Number:

Report Date:

MANCHESTER VPME

R2020005.000

L2035539

2,4,5,6-Tetrachloro-m-xylene

Decachlorobiphenyl

2,4,5,6-Tetrachloro-m-xylene

Decachlorobiphenyl

30-150

Acceptance Criteria

Surrogate % Recovery Qualifier Column

09/04/20

PCB-01-WINDOW CAULKClient ID:

08/27/20 12:00Date Collected:

08/28/20Date Received:

MANCHESTER, NHSample Location:

L2035539-01Lab ID:

Field Prep: Not Specified

Matrix: Solid Extraction Method:

Cleanup Method:

Analytical Method:

Analytical Date:

Analyst:

1,8082A 09/01/20 14:52

JAW

EPA 3540C

EPA 3630

Extraction Date: 08/31/20 15:15

Cleanup Date: 09/01/20 Cleanup Method: EPA 3665A Cleanup Date: 09/01/20

Percent Solids: Results reported on an 'AS RECEIVED' basis.

MDL

Column

EPA 3660B

09/01/20

Cleanup Method:

Cleanup Date:

Sample Depth:

Aroclor 1221

Aroclor 1232

Aroclor 1242

Aroclor 1248

Aroclor 1254

Aroclor 1260

Aroclor 1262

Aroclor 1268

PCBs, Total

Parameter Result Dilution Factor

ug/kg ug/kg ug/kg ug/kg ug/kg ug/kg ug/kg ug/kg ug/kg ug/kg

Qualifier Units RL

Polychlorinated Biphenyls by GC - Westborough Lab

SAMPLE RESULTS

Project Name:

Project Number:

Lab Number:

Report Date:

MANCHESTER VPME

R2020005.000

L2035539

2,4,5,6-Tetrachloro-m-xylene

Decachlorobiphenyl

2,4,5,6-Tetrachloro-m-xylene

Decachlorobiphenyl

30-150

Acceptance Criteria

Surrogate % Recovery Qualifier Column

09/04/20

PCB-02-DOOR CAULKClient ID:

08/27/20 12:00Date Collected:

08/28/20Date Received:

MANCHESTER, NHSample Location:

L2035539-02Lab ID:

Field Prep: Not Specified

Matrix: Solid Extraction Method:

Cleanup Method:

Analytical Method:

Analytical Date:

Analyst:

1,8082A 09/01/20 14:59

JAW

EPA 3540C

EPA 3630

Extraction Date: 08/31/20 15:15

Cleanup Date: 09/01/20 Cleanup Method: EPA 3665A Cleanup Date: 09/01/20

Percent Solids: Results reported on an 'AS RECEIVED' basis.

MDL

Column

EPA 3660B

09/01/20

Cleanup Method:

Cleanup Date:

Sample Depth:

Method Blank Analysis Batch Quality Control

Project Name:

Project Number:

Lab Number:

Report Date:

MANCHESTER VPME

R2020005.000

L2035539

09/01/20 14:27 1,8082AAnalytical Method:

Analytical Date:

Extraction Method:

Cleanup Method:

EPA 3540C

EPA 3630

Extraction Date: 08/31/20 15:15

09/04/20

Cleanup Method: EPA 3665A

Analyst: JAW

Aroclor 1016

Aroclor 1221

Aroclor 1232

Aroclor 1242

Aroclor 1248

Aroclor 1254

Aroclor 1260

Aroclor 1262

Aroclor 1268

PCBs, Total

Parameter Result

ug/kg ug/kg ug/kg ug/kg ug/kg ug/kg ug/kg ug/kg ug/kg ug/kg

UnitsQualifier

Polychlorinated Biphenyls by GC - Westborough Lab for sample(s): 01-02 Batch: WG1404914-1

2,4,5,6-Tetrachloro-m-xylene

Decachlorobiphenyl

2,4,5,6-Tetrachloro-m-xylene

Decachlorobiphenyl

30-150

Surrogate %Recovery Qualifier Column Acceptance

Criteria

Cleanup Date: 09/01/20

MDL

Column

Cleanup Method: EPA 3660B Cleanup Date: 09/01/20

Aroclor 1260

40-140

Parameter

LCS

%Recovery

LCSD

%Recovery %Recovery

Limits RPD

RPD

Limits

Polychlorinated Biphenyls by GC - Westborough Lab Associated sample(s): 01-02 Batch: WG1404914-2 WG1404914-3

Lab Control Sample Analysis Batch Quality Control

Project Name:

Project Number:

Lab Number:

Report Date:

MANCHESTER VPME

R2020005.000

L2035539

2,4,5,6-Tetrachloro-m-xylene Decachlorobiphenyl 2,4,5,6-Tetrachloro-m-xylene Decachlorobiphenyl

30-150 30-150 30-150 30-150

A A B B

Surrogate Qual Column%Recovery Qual%Recovery

LCS LCSD

09/04/20

Acceptance Criteria

Qual Qual Qual Column

*Values in parentheses indicate holding time in days

L2035539-01A

L2035539-02A

Glass 120ml/4oz unpreserved

2.4

Absent

A Absent Cooler Custody Seal Cooler Information

MANCHESTER VPME

R2020005.000

PCB-8082-CAULK(14)

Project Name:

Project Number:

L2035539Lab Number:

Report Date:

Sample Receipt and Container Information

Container ID Container Type Cooler Temp deg C Pres Seal

Container Information

Analysis(*)

09/04/20

Were project specific reporting limits specified? YES

Frozen Date/Time

Final pH

Initial pH

Report Format: Data Usability Report

GLOSSARY

Project Name:

Project Number:

Lab Number:

Report Date:

L2035539MANCHESTER VPME

R2020005.000 09/04/20

Acronyms

EDL

EMPC

EPA

LCS

LCSD

LFB

LOD

LOQ

MDL

MSD

NDPA/DPA

RPD

SRM

STLP

TEF

TEQ

TIC

Detection Limit: This value represents the level to which target analyte concentrations are reported as estimated values, when those target analyte concentrations are quantified below the limit of quantitation (LOQ). The DL includes any adjustments from dilutions, concentrations or moisture content, where applicable. (DoD report formats only.)

Estimated Detection Limit: This value represents the level to which target analyte concentrations are reported as estimated values, when those target analyte concentrations are quantified below the reporting limit (RL). The EDL includes any adjustments from dilutions, concentrations or moisture content, where applicable. The use of EDLs is specific to the analysis of PAHs using Solid-Phase Microextraction (SPME).

Estimated Maximum Possible Concentration: The concentration that results from the signal present at the retention time of an analyte when the ions meet all of the identification criteria except the ion abundance ratio criteria. An EMPC is a worst-case estimate of the concentration.

Environmental Protection Agency.

Laboratory Control Sample: A sample matrix, free from the analytes of interest, spiked with verified known amounts of analytes or a material containing known and verified amounts of analytes.

Laboratory Control Sample Duplicate: Refer to LCS.

Laboratory Fortified Blank: A sample matrix, free from the analytes of interest, spiked with verified known amounts of analytes or a material containing known and verified amounts of analytes.

Limit of Detection: This value represents the level to which a target analyte can reliably be detected for a specific analyte in a specific matrix by a specific method. The LOD includes any adjustments from dilutions, concentrations or moisture content, where applicable. (DoD report formats only.)

Limit of Quantitation: The value at which an instrument can accurately measure an analyte at a specific concentration. The LOQ includes any adjustments from dilutions, concentrations or moisture content, where applicable. (DoD report formats only.)

Method Detection Limit: This value represents the level to which target analyte concentrations are reported as estimated values, when those target analyte concentrations are quantified below the reporting limit (RL). The MDL includes any adjustments from dilutions, concentrations or moisture content, where applicable.

Matrix Spike Sample: A sample prepared by adding a known mass of target analyte to a specified amount of matrix sample for which an independent estimate of target analyte concentration is available. For Method 332.0, the spike recovery is calculated using the native concentration, including estimated values.

Matrix Spike Sample Duplicate: Refer to MS.

Not Applicable.

Not Calculated: Term is utilized when one or more of the results utilized in the calculation are non-detect at the parameter's reporting unit.

N-Nitrosodiphenylamine/Diphenylamine.

Not Ignitable.

Non-Plastic: Term is utilized for the analysis of Atterberg Limits in soil.

Reporting Limit: The value at which an instrument can accurately measure an analyte at a specific concentration. The RL includes any adjustments from dilutions, concentrations or moisture content, where applicable.

Relative Percent Difference: The results from matrix and/or matrix spike duplicates are primarily designed to assess the precision of analytical results in a given matrix and are expressed as relative percent difference (RPD). Values which are less than five times the reporting limit for any individual parameter are evaluated by utilizing the absolute difference between the values; although the RPD value will be provided in the report.

Standard Reference Material: A reference sample of a known or certified value that is of the same or similar matrix as the associated field samples.

Semi-dynamic Tank Leaching Procedure per EPA Method 1315.

Toxic Equivalency Factors: The values assigned to each dioxin and furan to evaluate their toxicity relative to 2,3,7,8-TCDD.

Toxic Equivalent: The measure of a sample's toxicity derived by multiplying each dioxin and furan by its corresponding TEF and then summing the resulting values.

Tentatively Identified Compound: A compound that has been identified to be present and is not part of the target compound list (TCL) for the method and/or program. All TICs are qualitatively identified and reported as estimated concentrations.

Footnotes

Project Name:

Project Number:

Lab Number:

Report Date:

L2035539MANCHESTER VPME

R2020005.000 09/04/20

Terms

Analytical Method: Both the document from which the method originates and the analytical reference method. (Example: EPA 8260B is shown as 1,8260B.) The codes for the reference method documents are provided in the References section of the Addendum.

Difference: With respect to Total Oxidizable Precursor (TOP) Assay analysis, the difference is defined as the Post-Treatment value minus the Pre-Treatment value.

Final pH: As it pertains to Sample Receipt & Container Information section of the report, Final pH reflects pH of container determined after adjustment at the laboratory, if applicable. If no adjustment required, value reflects Initial pH.

Frozen Date/Time: With respect to Volatile Organics in soil, Frozen Date/Time reflects the date/time at which associated Reagent Water-preserved vials were initially frozen. Note: If frozen date/time is beyond 48 hours from sample collection, value will be reflected in 'bold'.

Initial pH: As it pertains to Sample Receipt & Container Information section of the report, Initial pH reflects pH of container determined upon receipt, if applicable.

PAH Total: With respect to Alkylated PAH analyses, the 'PAHs, Total' result is defined as the summation of results for all or a subset of the following compounds: Naphthalene, C1-C4 Naphthalenes, 2-Methylnaphthalene, 1-Methylnaphthalene, Biphenyl, Acenaphthylene, Acenaphthene, Fluorene, C1-C3 Fluorenes, Phenanthrene, C1-C4 Phenanthrenes/Anthracenes, Anthracene, Fluoranthene, Pyrene, C1-C4 Fluoranthenes/Pyrenes, Benz(a)anthracene, Chrysene, C1-C4 Chrysenes, Benzo(b)fluoranthene, Benzo(j)+(k)fluoranthene, Benzo(e)pyrene, Benzo(a)pyrene, Perylene, Indeno(1,2,3-cd)pyrene, Dibenz(ah)+(ac)anthracene, Benzo(g,h,i)perylene. If a 'Total' result is requested, the results of its individual components will also be reported.

PFAS Total: With respect to PFAS analyses, the 'PFAS, Total (5)' result is defined as the summation of results for: PFHpA, PFHxS, PFOA, PFNA and PFOS. If a 'Total' result is requested, the results of its individual components will also be reported.

The target compound Chlordane (CAS No. 57-74-9) is reported for GC ECD analyses. Per EPA,this compound "refers to a mixture of chlordane isomers, other chlorinated hydrocarbons and numerous other components." (Reference: USEPA Toxicological Review of Chlordane, In Support of Summary Information on the Integrated Risk Information System (IRIS), December 1997.)

Total: With respect to Organic analyses, a 'Total' result is defined as the summation of results for individual isomers or Aroclors. If a 'Total' result is requested, the results of its individual components will also be reported. This is applicable to 'Total' results for methods 8260, 8081 and 8082.

Data Qualifiers

Spectra identified as "Aldol Condensates" are byproducts of the extraction/concentration procedures when acetone is introduced in the process.

The analyte was detected above the reporting limit in the associated method blank. Flag only applies to associated field samples that have detectable concentrations of the analyte at less than ten times (10x) the concentration found in the blank. For MCP-related projects, flag only applies to associated field samples that have detectable concentrations of the analyte at less than ten times (10x) the concentration found in the blank. For DOD-related projects, flag only applies to associated field samples that have detectable concentrations of the analyte at less than ten times (10x) the concentration found in the blank AND the analyte was detected above one-half the reporting limit (or above the reporting limit for common lab contaminants) in the associated method blank. For NJ- Air-related projects, flag only applies to associated field samples that have detectable concentrations of the analyte above the reporting limit. For NJ-related projects (excluding Air), flag only applies to associated field samples that have detectable concentrations of the analyte, which was detected above the reporting limit in the associated method blank or above five times the reporting limit for common lab contaminants (Phthalates, Acetone, Methylene Chloride, 2-Butanone).

Co-elution: The target analyte co-elutes with a known lab standard (i.e. surrogate, internal standards, etc.) for co-extracted analyses.

Concentration of analyte was quantified from diluted analysis. Flag only applies to field samples that have detectable concentrations of the analyte.

Concentration of analyte exceeds the range of the calibration curve and/or linear range of the instrument.

The ratio of quantifier ion response to qualifier ion response falls outside of the laboratory criteria. Results are considered to be an estimated maximum concentration.

The concentration may be biased high due to matrix interferences (i.e, co-elution) with non-target compound(s). The result should be considered estimated.

The analysis of pH was performed beyond the regulatory-required holding time of 15 minutes from the time of sample collection.

The lower value for the two columns has been reported due to obvious interference.

Estimated value. This represents an estimated concentration for Tentatively Identified Compounds (TICs).

Reporting Limit (RL) exceeds the MCP CAM Reporting Limit for this analyte.

Not detected at the reporting limit (RL) for the sample.

Presumptive evidence of compound. This represents an estimated concentration for Tentatively Identified Compounds (TICs), where the identification is based on a mass spectral library search.

The RPD between the results for the two columns exceeds the method-specified criteria.

The quality control sample exceeds the associated acceptance criteria. For DOD-related projects, LCS and/or Continuing Calibration

1 The reference for this analyte should be considered modified since this analyte is absent from the target analyte list of the original method.

Project Name:

Project Number:

Lab Number:

Report Date:

L2035539MANCHESTER VPME

R2020005.000 09/04/20

Data Qualifiers

Standard exceedences are also qualified on all associated sample results. Note: This flag is not applicable for matrix spike recoveries when the sample concentration is greater than 4x the spike added or for batch duplicate RPD when the sample concentrations are less than 5x the RL. (Metals only.)

Analytical results are from sample re-analysis.

Analytical results are from sample re-extraction.

Analytical results are from modified screening analysis.

Alpha Analytical performs services with reasonable care and diligence normal to the analytical testing laboratory industry. In the event of an error, the sole and exclusive responsibility of Alpha Analytical shall be to re-perform the work at it's own expense. In no event shall Alpha Analytical be held liable for any incidental, consequential or special damages, including but not limited to, damages in any way connected with the use of, interpretation of, information or analysis provided by Alpha Analytical.

We strongly urge our clients to comply with EPA protocol regarding sample volume, preservation, cooling, containers, sampling procedures, holding time and splitting of samples in the field.

LIMITATION OF LIABILITIES

1 Test Methods for Evaluating Solid Waste: Physical/Chemical Methods. EPA SW-846.

Third Edition. Updates I - VI, 2018.

Project Name:

Project Number:

Lab Number:

Report Date:

L2035539MANCHESTER VPME

R2020005.000

REFERENCES

09/04/20

Alpha Analytical, Inc. ID No.:17873 Facility: Company-wide Revision 17 Department: Quality Assurance Published Date: 4/28/2020 9:42:21 AM Title: Certificate/Approval Program Summary Page 1 of 1

Document Type: Form Pre-Qualtrax Document ID: 08-113

Certification Information

The following analytes are not included in our Primary NELAP Scope of Accreditation:

Westborough Facility EPA 624/624.1: m/p-xylene, o-xylene, Naphthalene EPA 8260C: NPW: 1,2,4,5-Tetramethylbenzene; 4-Ethyltoluene, Azobenzene; SCM: Iodomethane (methyl iodide), 1,2,4,5-Tetramethylbenzene; 4- Ethyltoluene.

EPA 8270D: NPW: Dimethylnaphthalene,1,4-Diphenylhydrazine; SCM: Dimethylnaphthalene,1,4-Diphenylhydrazine.

SM4500: NPW: Amenable Cyanide; SCM: Total Phosphorus, TKN, NO2, NO3.

Mansfield Facility

SM 2540D: TSS

EPA 8082A: NPW: PCB: 1, 5, 31, 87,101, 110, 141, 151, 153, 180, 183, 187.

EPA TO-15: Halothane, 2,4,4-Trimethyl-2-pentene, 2,4,4-Trimethyl-1-pentene, Thiophene, 2-Methylthiophene, 3-Methylthiophene, 2-Ethylthiophene, 1,2,3-Trimethylbenzene, Indan, Indene, 1,2,4,5-Tetramethylbenzene, Benzothiophene, 1-Methylnaphthalene.

EPA TO-12 Non-methane organics EPA 3C Fixed gases Biological Tissue Matrix: EPA 3050B

The following analytes are included in our Massachusetts DEP Scope of Accreditation

Westborough Facility:

Drinking Water EPA 300.0: Chloride, Nitrate-N, Fluoride, Sulfate; EPA 353.2: Nitrate-N, Nitrite-N; SM4500NO3-F: Nitrate-N, Nitrite-N; SM4500F-C, SM4500CN-CE, EPA 180.1, SM2130B, SM4500Cl-D, SM2320B, SM2540C, SM4500H-B, SM4500NO2-B EPA 332: Perchlorate; EPA 524.2: THMs and VOCs; EPA 504.1: EDB, DBCP.

Microbiology: SM9215B; SM9223-P/A, SM9223B-Colilert-QT,SM9222D.

Non-Potable Water SM4500H,B, EPA 120.1, SM2510B, SM2540C, SM2320B, SM4500CL-E, SM4500F-BC, SM4500NH3-BH: Ammonia-N and Kjeldahl-N, EPA 350.1:

Ammonia-N, LACHAT 10-107-06-1-B: Ammonia-N, EPA 351.1, SM4500NO3-F, EPA 353.2: Nitrate-N, SM4500P-E, SM4500P-B, E, SM4500SO4-E, SM5220D, EPA 410.4, SM5210B, SM5310C, SM4500CL-D, EPA 1664, EPA 420.1, SM4500-CN-CE, SM2540D, EPA 300: Chloride, Sulfate, Nitrate.

EPA…

This is the start of the file's text. The full file is on GovTribe.

File details come from the government source that posted it. Updated Aug 1, 2023.